Sientra Overview
Valuation check: SIEN's ROE is 199.18%, above the Healthcare sector average of 20.86%.
Get informed when a big investor buys or sells
+ Follow199.18%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Sientra (SIEN) currently reports a ROE of 199.18%. That is above the Healthcare sector average of 20.86%. Use the charts on this page to explore Sientra's ROE history and peer comparisons.
Sientra's ROE of 199.18% is higher than the Healthcare sector average of 20.86%. That is roughly 855.0% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Sientra's current 199.18% should be judged against Healthcare norms (sector average: 20.86%) and against SIEN's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 199.18%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 20.86%. From there, open related valuation or income-statement pages for Sientra, and consider following SIEN for alerts when major investors trade the stock.
Sientra is classified in the Healthcare sector. On ROE, it currently shows 199.18% versus a sector average near 20.86%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SIEN with unrelated industries.
